PeterALaneJr.MD
Pediatric Hematology & Oncology • Atlanta, GAPediatric Anemia and Red Blood Cell Hematology
Professor, Pediatrics, Emory University School of Medicine
Dr. Lane is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
35 Jesse Hill Jr Dr SE
Atlanta, GA 30303Phone+1 404-785-9800Fax+1 404-785-9745
Education & Training
University of California (San Francisco)Fellowship, Pediatric Hematology/Oncology, 1984 - 1987
University of ColoradoFellowship, Pediatric Hematology/Oncology, 1982 - 1984- University of ColoradoResidency, Pediatrics, 1978 - 1982
University of Cincinnati College of MedicineClass of 1978
Certifications & Licensure
CA State Medical License 1984 - Present
GA State Medical License 2002 - 2025
CO State Medical License 1981 - 2009- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Publications & Presentations
PubMed
- 95 citationsImpact of red blood cell alloimmunization on sickle cell disease mortality: a case series.Robert Sheppard Nickel, Jeanne E. Hendrickson, Ross M. Fasano, Erin K. Meyer, Anne M. Winkler
Transfusion. 2016-01-01 - 131 citationsA two-year pilot trial of hydroxyurea in very young children with sickle-cell anemia☆Winfred C. Wang, Lynn W. Wynn, Zora R. Rogers, J. Paul Scott, Peter A. Lane
The Journal of Pediatrics. 2001-12-01 - 84 citationsBiomarkers of splenic function in infants with sickle cell anemia: baseline data from the BABY HUG TrialZora R. Rogers, Winfred C. Wang, Zhaoyu Luo, Rathi V. Iyer, Eglal Shalaby-Rana
Blood. 2011-03-03
Abstracts/Posters
- Engagement in Cognitive-Behavioral Therapy for Chronic Pain Management Is Associated with Reductions in Healthcare Utilization in Pediatric Sickle Cell DiseasePeter A. Lane, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Safety of Intravenous Arginine Therapy in Children with Sickle Cell Disease Hospitalized for Vaso-Occlusive Pain: A Randomized Placebo-Controlled Trial in ProgressPeter A. Lane, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Social Vulnerability Is Associated with Emergency Department Dependency in Pediatric Sickle Cell Disease PatientsPeter A. Lane, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Press Mentions
- These Sisters with Sickle Cell Had Devastating — and Preventable — StrokesMay 23rd, 2021
- These Sisters with Sickle Cell Had Devastating, and Preventable, StrokesMay 23rd, 2021
Grant Support
- Serum Amino Acid Concentrations &Nutrition In Children W/ Sickle Cell DiseaseNational Center For Research Resources1999–2002
- Chronic Transfusion And Therapy For Refractory AnemiasNational Center For Research Resources1994–1995
- Study Of Splenic Function In Sickle Hemoglobin C DiseaseNational Center For Research Resources1994
- Study Of Splenic Function In Sickle-Hemoglobin C DiseaseNational Center For Research Resources1993
- Vitamin K Storage And Requirements In Sick Human NewbornsNational Center For Research Resources1985–1988
- Congenital Hemolytic AnemiasNational Center For Research Resources1985–1986
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
